HopeAI Unveils AI Synthetic Data to Accelerate Cancer Trials
HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical...
Category : Clinical Trials
Apriori Bio Announces Collaboration with the Francis Crick Institute
Apriori to leverage foundational insights from the Crick’s Legacy Study to further validate Octavia™ platform’s ability to predict viral evolution and vaccine performance Apriori Bio, a...
Turbine Partners with MSD to AI-Study Hard-to-Treat Cancers
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ...
MASSIVE BIO Launches Live Patient Connect & AI Trial Assistant
In direct support of the White House and CMS’s bold initiative to “Make Health Tech Great Again,” Massive Bio, leader in AI-enabled oncology trial matching, announced its...
Everads Shares Clinical Trial Results at ASRS 2025 Meeting
– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using...
BioArctic: AI-Driven Data Reinforces Lecanemab’s Safety & Efficacy
BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai presented the latest findings on lecanemab (Leqembi®) at the Alzheimer’s Association International Conference (AAIC), held in Toronto, July 27 to...
Unlearn Appoints Its First Vice President of Product
Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovation Unlearn®, a leader in AI...
Komodo & Anervea Partner to Advance AI in Clinical Development
Anervea to Build Breakthrough ClinDev Optimization Suite on Komodo’s MapLab Enterprise, Harnessing Real-World Data and AI to Accelerate Market Access and Improve Patient Outcomes Komodo...
Lantern Pharma Sees Response in Lymphoma Patient with LP-284
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage oncology company leveraging its proprietary RADR® artificial intelligence (AI) platform to systematically transform drug discovery paradigms, today announces...
Linus Health Advances Early Brain Health Detection at AAIC 2025
Powering Alzheimer’s research with AI-driven insights across cognition, meaning, motor function, and speech — accelerating study recruitment and enabling more equitable, personalized brain health care Linus Health,...